1. 2022
  2. Assessment of functional shunting in patients with sickle cell disease

    Afzali-Hashemi, L., Václavů, L., Wood, J. C., Biemond, B. J., Nederveen, A. J., Mutsaerts, H. J. M. M. & Schrantee, A., 1 Nov 2022, In: Haematologica. 107, 11, p. 2708-2719 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis

    Meeuwes, F. O., Brink, M., van der Poel, M. W. M., Kersten, M. J., Wondergem, M., Mutsaers, P. G. N. J., Böhmer, L., Woei-A-Jin, S., Visser, O., Oostvogels, R., Jansen, P. M., Diepstra, A., Snijders, T. J. F., Plattel, W. J., Huls, G. A., Vermaat, J. S. P. & Nijland, M., 1 Nov 2022, In: European Journal of Cancer. 176, p. 100-109 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study

    de Vos, T. W., Winkelhorst, D., Árnadóttir, V., van der Bom, J. G., Canals Surís, C., Caram-Deelder, C., Deschmann, E., Haysom, H. E., Hverven, H. B. C., Lozar Krivec, J., McQuilten, Z. K., Muñiz-Diaz, E., Nogués, N. R., Oepkes, D., Porcelijn, L., van der Schoot, C. E., Saxonhouse, M., Sola-Visner, M., Tiblad, E., Tiller, H., & 5 othersWood, E. M., Young, V., Železnik, M., de Haas, M. & Lopriore, E., 1 Nov 2022, In: The Lancet Haematology. 9, 11, p. e844-e853

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication

    Helgers, L. C., Bhoekhan, M. S., Pajkrt, D., Wolthers, K. C., Geijtenbeek, T. B. H. & Sridhar, A., Nov 2022, In: Microbiology spectrum. 10, 6, p. e0282222

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

    van Rhee, K. P., de Vroom, S. L., van Hest, R. M., van der Linden, P. D., Tonino, S. H., Molendijk, E., Mathôt, R. A. A., Blijlevens, N. M. A., Knibbe, C. A. J., Bruggemann, R. J. M. & Geerlings, S. E., 28 Oct 2022, In: The Journal of antimicrobial chemotherapy. 77, 11, p. 3069-3076 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation

    van Lier, Y. F., Krabbendam, L., Haverkate, N. J. E., Zeerleder, S. S., Rutten, C. E., Blom, B., Spits, H. & Hazenberg, M. D., 3 Oct 2022, In: Frontiers in immunology. 13, 1020590.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

    COBRA KAI Study Team, Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., & 9 othersGroen, K., van Meerten, T., Mutsaers, P. G. N. J., Beaumont, T., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 1 Oct 2022, In: JAMA oncology. 8, 10, p. 1477-1483 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M-D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B., & 2 othersNiemann, C. & Kater, A., 1 Oct 2022, In: Clinical lymphoma, myeloma & leukemia. 22, p. S264-S265

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets

    van Osch, T. L. J., Oosterhoff, J. J., Bentlage, A. E. H., Nouta, J., Koeleman, C. A. M., Geerdes, D. M., Mok, J. Y., Heidt, S., Mulder, A., van Esch, W. J. E., Kapur, R., Porcelijn, L., van der Schoot, C. E., de Haas, M., Wuhrer, M., Voorberg, J. & Vidarsson, G., 1 Oct 2022, In: Haematologica. 107, 10, p. 2432-2444 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity

    Oosterhoff, J. J., Larsen, M. D., van der Schoot, C. E. & Vidarsson, G., Oct 2022, In: Trends in immunology. 43, 10, p. 800-814 15 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...130 Next

ID: 19903